No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d2qbrA_, 1.0000, 0.00, 1.000, 298, 298, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
2, d1ptyA_, 0.9983, 0.26, 0.997, 298, 298, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH TWO PHOSPHOTYROSINE MOLECULES
3, p6b8eA_, 0.9979, 0.29, 0.993, 298, 298, MULTICONFORMER MODEL OF APO WT PTP1B WITH GLYCEROL AT 180 K 
4, d1xboA_, 0.9978, 0.30, 1.000, 298, 298, PTP1B COMPLEXED WITH ISOXAZOLE CARBOXYLIC ACID
5, p6b90A_, 0.9977, 0.31, 1.000, 298, 298, MULTICONFORMER MODEL OF APO WT PTP1B WITH GLYCEROL AT 100 K (ALTERNATIVE REFINEMENT OF PDB 1SUG SHOWING CONFORMATIONAL HETEROGENEITY) 
6, d3i80A_, 0.9977, 0.30, 1.000, 298, 298, PROTEIN TYROSINE PHOSPHATASE 1B - TRANSITION STATE ANALOG FOR THE SECOND CATALYTIC STEP
7, d4i8nA_, 0.9975, 0.33, 1.000, 298, 298, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN INHIBITOR [(4-{(2S)-2-(13-BENZOXAZOL-2-YL)-2-[(4-FLUOROPHENYL) SULFAMOYL]ETHYL}PHENYL)AMINO](OXO)ACETIC ACID
8, d1sugA_, 0.9973, 0.33, 1.000, 298, 298, 1.95 A STRUCTURE OF APO PROTEIN TYROSINE PHOSPHATASE 1B
9, d1q1mA_, 0.9973, 0.33, 1.000, 298, 298, A HIGHLY EFFICIENT APPROACH TO A SELECTIVE AND CELL ACTIVE PTP1B INHIBITORS
10, p6b8tA_, 0.9961, 0.40, 0.993, 299, 298, MULTICONFORMER MODEL OF APO WT PTP1B WITH GLYCEROL AT 240 K 
11, d2zn7A_, 0.9960, 0.16, 1.000, 297, 297, CRYSTAL STRUCTURES OF PTP1B-INHIBITOR COMPLEXES
12, d2hb1A_, 0.9959, 0.16, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B WITH MONOCYCLIC THIOPHENE INHIBITOR
13, d2qbsA_, 0.9958, 0.18, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
14, d2qbqA_, 0.9958, 0.18, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
15, d2azrA_, 0.9958, 0.18, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B WITH BICYCLIC THIOPHENE INHIBITOR
16, d2zmmA_, 0.9957, 0.20, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
17, d2h4kA_, 0.9957, 0.19, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B WITH A MONOCYCLIC THIOPHENE INHIBITOR
18, d2b07A_, 0.9957, 0.19, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B WITH TRICYCLIC THIOPHENE INHIBITOR.
19, d2h4gA_, 0.9956, 0.20, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B WITH MONOCYCLIC THIOPHENE INHIBITOR
20, d2ntaA_, 0.9954, 0.22, 0.997, 297, 297, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
21, d2nt7A_, 0.9954, 0.22, 0.997, 297, 297, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
22, d2f70A_, 0.9954, 0.22, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
23, d2f6yA_, 0.9954, 0.22, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
24, d1aaxA_, 0.9954, 0.22, 0.997, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH TWO BIS(PARA-PHOSPHOPHENYL)METHANE (BPPM) MOLECULES
25, d5t19A1, 0.9953, 0.23, 1.000, 298, 297, STRUCTURE OF PTP1B COMPLEXED WITH N-(3 -(11-DIOXIDO-4-OXO-125- THIADIAZOLIDIN-2-YL)-4 -METHYL-[11 -BIPHENYL]-4-YL)ACETAMIDE
26, d2qbpA_, 0.9953, 0.23, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
27, d2f6wA_, 0.9953, 0.23, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
28, d2cm8A_, 0.9951, 0.24, 1.000, 297, 297, STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
29, d1pa1A1, 0.9951, 0.25, 0.997, 298, 297, CRYSTAL STRUCTURE OF THE C215D MUTANT OF PROTEIN TYROSINE PHOSPHATASE 1B
30, d1bzjA_, 0.9951, 0.25, 1.000, 297, 297, HUMAN PTP1B COMPLEXED WITH TPICOOH
31, d1eenA_, 0.9949, 0.49, 0.997, 299, 298, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH ACETYL-D-A-D-BPA-PTYR-L-I-P-Q-Q-G
32, d2f71A_, 0.9948, 0.49, 0.997, 299, 298, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
33, d2f6zA_, 0.9948, 0.28, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
34, d2f6tA_, 0.9948, 0.28, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
35, d1ptvA_, 0.9948, 0.28, 1.000, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH PHOSPHOTYROSINE
36, d2f6vA_, 0.9946, 0.27, 0.990, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
37, d1waxA_, 0.9946, 0.29, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH ACTIVE SITE INHIBITOR
38, d1c87A_, 0.9946, 0.28, 1.000, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 2-(OXALYL-AMINO-47-DIHYDRO-5H-THIENO[23- C]PYRAN-3-CARBOXYLIC ACID
39, d1l8gA_, 0.9942, 0.29, 0.993, 297, 297, CRYSTAL STRUCTURE OF PTP1B COMPLEXED WITH 7-(11-DIOXO-1H- BENZO[D]ISOTHIAZOL-3-YLOXYMETHYL)-2-(OXALYL-AMINO)-47- DIHYDRO-5H-THIENO[23-C]PYRAN-3-CARBOXYLIC ACID
40, d1ecvA_, 0.9942, 0.31, 0.993, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 5-IODO-2-(OXALYL-AMINO)-BENZOIC ACID
41, d1c88A_, 0.9940, 0.31, 0.993, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 2-(OXALYL-AMINO)-4567-TETRAHYDRO- THIENO[23-C]PYRIDINE-3-CARBOXYLIC ACID
42, d1c85A_, 0.9940, 0.33, 0.993, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 2-(OXALYL-AMINO)-BENZOIC ACID
43, d2cniA_, 0.9937, 0.33, 0.993, 297, 297, STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
44, d1c84A_, 0.9936, 0.55, 1.000, 299, 298, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 3-(OXALYL-AMINO)-NAPHTHALENE-2-CARBOXLIC ACID
45, d2vevA_, 0.9935, 0.35, 0.993, 297, 297, CRYSTAL STRUCUTRE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR
46, d1c83A_, 0.9935, 0.56, 1.000, 298, 298, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID
47, d1ptuA_, 0.9926, 0.36, 0.993, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH PHOSPHOTYROSINE-CONTAINING HEXA-PEPTIDE (DADEPYL-NH2)
48, d2bgeA_, 0.9919, 0.41, 0.993, 297, 297, STRUCTURE-BASED DESIGN OF PROTEIN TYROSINE PHOSPHATASE-1B INHIBITORS
49, p6b8xA_, 0.9918, 0.23, 1.000, 297, 296, MULTICONFORMER MODEL OF APO WT PTP1B WITH GLYCEROL AT 278 K 
50, d1pttA_, 0.9918, 0.44, 0.993, 298, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH PHOSPHOTYROSINE-CONTAINING TETRA-PEPTIDE (AC-DEPYL-NH2)
51, d1c86A_, 0.9917, 0.45, 0.993, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (R47V D48N) COMPLEXED WITH 2-(OXALYL-AMINO-47-DIHYDRO-5H- THIENO[23-C]PYRAN-3-CARBOXYLIC ACID
52, d1gfyA_, 0.9916, 0.25, 0.986, 296, 296, RESIDUE 259 IS A KEY DETERMINANT OF SUBSTRATE SPECIFICITY OF PROTEIN-TYROSINE PHOSPHATASE 1B AND ALPHA
53, d1g7gA_, 0.9913, 0.26, 0.980, 296, 296, HUMAN PTP1B CATALYTIC DOMAIN COMPLEXES WITH PNU179326
54, d5k9wA1, 0.9912, 0.48, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B (1-301) IN COMPLEX WITH TCS401 CLOSED STATE
55, d1pxhA_, 0.9911, 0.29, 1.000, 297, 296, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B WITH POTENT AND SELECTIVE BIDENTATE INHIBITOR COMPOUND 2
56, d1g1fA_, 0.9911, 0.52, 1.000, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A TRI-PHOSPHORYLATED PEPTIDE (RDI(PTR) ETD(PTR)(PTR)RK) FROM THE INSULIN RECEPTOR KINASE
57, p3i7zA_, 0.9910, 0.50, 0.997, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B - TRANSITION STATE ANALOG FOR THE FIRST CATALYTIC STEP
58, d2vexA_, 0.9910, 0.52, 1.000, 297, 297, CRYSTAL STRUCUTRE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR
59, d1n6wA_, 0.9910, 0.52, 1.000, 297, 297,  
60, d4qbwA_, 0.9907, 0.52, 1.000, 297, 297, THE SECOND SPHERE RESIDUE T263 IS IMPORTANT FOR FUNCTION AND ACTIVITY OF PTP1B THROUGH MODULATING WPD LOOP
61, d4qapA_, 0.9907, 0.70, 1.000, 299, 298, THE SECOND SPHERE RESIDUE T263 IS IMPORTANT FOR FUNCTION AND ACTIVITY OF PTP1B THROUGH MODULATING WPD LOOP
62, d5ka7A1, 0.9905, 0.70, 0.997, 299, 298, PROTEIN TYROSINE PHOSPHATASE 1B T178A MUTANT IN COMPLEX WITH TCS401 CLOSED STATE
63, d3qkqA_, 0.9905, 0.33, 0.997, 297, 296, PROTEIN TYROSINE PHOSPHATASE 1B - W179F MUTANT BOUND WITH VANADATE
64, d2veyA_, 0.9905, 0.33, 0.997, 296, 296, CRYSTAL STRUCUTRE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR
65, d1nweA_, 0.9905, 0.54, 1.000, 297, 297, PTP1B R47C MODIFIED AT C47 WITH N-[4-(2-{2-[3-(2-BROMO- ACETYLAMINO)-PROPIONYLAMINO]-3-HYDROXY-PROPIONYLAMINO}- ETHYL)-PHENYL]-OXALAMIC ACID
66, d1g1gA_, 0.9905, 0.34, 0.990, 296, 296, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A MONO-PHOSPHORYLATED PEPTIDE (ETDY(PTR) RKGGKGLL) FROM THE INSULIN RECEPTOR KINASE
67, d1eeoA_, 0.9902, 0.52, 0.997, 298, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH ACETYL-E-L-E-F-PTYR-M-D-Y-E-NH2
68, d2cngA_, 0.9897, 0.56, 0.997, 297, 297, STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
69, d1bzcA_, 0.9891, 0.39, 1.000, 296, 296, HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH TPI
70, p4zrtA_, 0.9890, 0.61, 0.993, 297, 297, PTP1BC215S BOUND TO NEPHRIN PEPTIDE SUBSTRATE
71, d1kavA_, 0.9883, 0.62, 0.997, 297, 297, HUMAN TYROSINE PHOSPHATASE 1B COMPLEXED WITH AN INHIBITOR
72, d2vewA_, 0.9876, 0.62, 1.000, 297, 297, CRYSTAL STRUCUTRE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR
73, d2cnfA_, 0.9875, 0.52, 1.000, 296, 296, STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
74, d2cnhA_, 0.9873, 0.53, 1.000, 296, 296, STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
75, d2veuA_, 0.9872, 0.54, 1.000, 296, 296, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR
76, d1g1hA_, 0.9868, 0.52, 1.000, 296, 296, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A BIS-PHOSPHORYLATED PEPTIDE (ETD(PTR)(PTR) RKGGKGLL) FROM THE INSULIN RECEPTOR KINASE
77, d2cm7A_, 0.9867, 0.65, 0.997, 298, 297, STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
78, d5ka3A_, 0.9866, 0.58, 1.000, 296, 296, PROTEIN TYROSINE PHOSPHATASE 1B YAYA (Y152A Y153A) MUTANT IN COMPLEX WITH TCS401 CLOSED STATE
79, d2cmaA_, 0.9865, 0.37, 0.993, 295, 295, STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
80, d1kakA_, 0.9865, 0.58, 1.000, 296, 296, HUMAN TYROSINE PHOSPHATASE 1B COMPLEXED WITH AN INHIBITOR
81, d4qahA_, 0.9852, 0.67, 1.000, 297, 297, THE SECOND SPHERE RESIDUE T263 IS IMPORTANT FOR FUNCTION AND ACTIVITY OF PTP1B THROUGH MODULATING WPD LOOP
82, d1g7fA_, 0.9835, 0.92, 0.997, 299, 298, HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177496
83, d4y14B_, 0.9823, 0.81, 0.997, 297, 297, STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH INHIBITOR (PTP1B:CPT157633)
84, d2bgdA_, 0.9818, 0.42, 1.000, 296, 294, STRUCTURE-BASED DESIGN OF PROTEIN TYROSINE PHOSPHATASE-1B INHIBITORS
85, d4qbeA_, 0.9800, 0.24, 1.000, 294, 293, THE SECOND SPHERE RESIDUE T263 IS IMPORTANT FOR FUNCTION AND ACTIVITY OF PTP1B THROUGH MODULATING WPD LOOP
86, d4y14A_, 0.9773, 0.93, 0.997, 298, 297, STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH INHIBITOR (PTP1B:CPT157633)
87, d1bzhA_, 0.9695, 0.51, 1.000, 293, 293, CYCLIC PEPTIDE INHIBITOR OF HUMAN PTP1B
88, d3qkpA_, 0.9636, 1.17, 0.993, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B - APO W179F MUTANT WITH OPEN WPD-LOOP
89, d2f6fA1, 0.9586, 0.70, 0.997, 291, 290, THE STRUCTURE OF THE S295F MUTANT OF HUMAN PTP1B
90, d1a5yA_, 0.9460, 1.59, 0.997, 298, 297, PROTEIN TYROSINE PHOSPHATASE 1B CYSTEINYL-PHOSPHATE INTERMEDIATE
91, d5ka9A1, 0.9450, 0.42, 0.989, 283, 283, PROTEIN TYROSINE PHOSPHATASE 1B L192A MUTANT IN COMPLEX WITH TCS401 OPEN STATE
92, d1qxkA_, 0.9386, 1.57, 0.956, 294, 293, MONOACID-BASED CELL PERMEABLE SELECTIVE INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
93, d1q6sA1, 0.9375, 0.62, 1.000, 282, 282, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 9
94, p6b95A_, 0.9365, 0.89, 1.000, 285, 284, MULTICONFORMER MODEL OF K197C PTP1B TETHERED TO COMPOUND 2 AT 100 K 
95, d1q6nB1, 0.9354, 0.93, 0.989, 285, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 4
96, d1q6tA1, 0.9349, 1.00, 0.993, 285, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 11
97, d1t48A_, 0.9336, 0.99, 1.000, 285, 284, ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B
98, d5ka1A1, 0.9326, 1.41, 0.979, 292, 287, PROTEIN TYROSINE PHOSPHATASE 1B DELTA HELIX 7 MUTANT IN COMPLEX WITH TCS401 CLOSED STATE
99, d4bjoA1, 0.9325, 0.72, 1.000, 282, 281, NITRATE IN THE ACTIVE SITE OF PTP1B IS A PUTATIVE MIMETIC OF THE TRANSITION STATE
100, d1lqfB1, 0.9318, 0.59, 1.000, 281, 280, STRUCTURE OF PTP1B IN COMPLEX WITH A PEPTIDIC BISPHOSPHONATE INHIBITOR
101, d1q6sB1, 0.9314, 0.88, 1.000, 283, 282, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 9
102, d2fjnA1, 0.9313, 1.20, 0.993, 285, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2
103, d1lqfC1, 0.9313, 1.09, 1.000, 285, 284, STRUCTURE OF PTP1B IN COMPLEX WITH A PEPTIDIC BISPHOSPHONATE INHIBITOR
104, d1lqfA1, 0.9310, 0.90, 1.000, 283, 282, STRUCTURE OF PTP1B IN COMPLEX WITH A PEPTIDIC BISPHOSPHONATE INHIBITOR
105, d1no6A_, 0.9309, 0.89, 1.000, 283, 282, POTENT SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 5 USING A LINKED-FRAGMENT STRATEGY
106, d1nz7A_, 0.9306, 0.90, 0.993, 282, 282, POTENT SELECTIVE INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B USING A SECOND PHOSPHOTYROSINE BINDING SITE COMPLEXED WITH COMPOUND 19.
107, d1onzA_, 0.9304, 0.91, 1.000, 282, 282, OXALYL-ARYL-AMINO BENZOIC ACID INHIBITORS OF PTP1B COMPOUND 8B
108, d3eaxA_, 0.9301, 0.91, 1.000, 282, 282, CRYSTAL STRUCTURE PTP1B COMPLEX WITH SMALL MOLECULE COMPOUND LZP-6
109, d1pynA_, 0.9301, 0.93, 0.996, 282, 282, DUAL-SITE POTENT SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR USING A LINKED FRAGMENT STRATEGY AND A MALONATE HEAD ON THE FIRST SITE
110, d1nl9A_, 0.9299, 0.92, 0.996, 282, 282, POTENT SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 12 USING A LINKED-FRAGMENT STRATEGY
111, d1lqfD1, 0.9297, 0.96, 0.993, 282, 282, STRUCTURE OF PTP1B IN COMPLEX WITH A PEPTIDIC BISPHOSPHONATE INHIBITOR
112, d1q6pA1, 0.9295, 0.96, 1.000, 283, 282, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 6
113, d1q6nA1, 0.9295, 0.97, 0.996, 283, 282, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 4
114, d1onyA_, 0.9295, 1.24, 1.000, 285, 284, OXALYL-ARYL-AMINO BENZOIC ACID INHIBITORS OF PTP1B COMPOUND 17
115, d1nnyA_, 0.9295, 0.93, 1.000, 282, 282, POTENT SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 23 USING A LINKED-FRAGMENT STRATEGY
116, d1ph0A_, 0.9287, 0.97, 0.993, 282, 282, NON-CARBOXYLIC ACID-CONTAINING INHIBITOR OF PTP1B TARGETING THE SECOND PHOSPHOTYROSINE SITE
117, d3eb1A_, 0.9283, 0.97, 0.996, 282, 282, CRYSTAL STRUCTURE PTP1B COMPLEX WITH SMALL MOLECULE INHIBITOR LZP-25
118, d1nwlA_, 0.9280, 1.10, 1.000, 283, 283, CRYSTAL STRUCTURE OF THE PTP1B COMPLEXED WITH SP7343-SP7964 A PTYR MIMETIC
119, d3d9cA_, 0.9269, 1.00, 0.986, 283, 282, CRYSTAL STRUCTURE PTP1B COMPLEX WITH ARYL SELENINIC ACID
120, p6baiA_, 0.9268, 1.02, 1.000, 282, 282, MULTICONFORMER MODEL OF APO K197C PTP1B AT 100 K 
121, d1q6mA1, 0.9268, 0.99, 0.982, 282, 282, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 3
122, d1jf7B_, 0.9262, 1.31, 1.000, 285, 284, HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177836
123, d5kadA1, 0.9261, 0.93, 1.000, 281, 281, PROTEIN TYROSINE PHOSPHATASE 1B N193A MUTANT IN COMPLEX WITH TCS401 CLOSED STATE
124, d1q6jA1, 0.9249, 0.94, 0.996, 281, 280, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2
125, d1q6tB1, 0.9248, 1.40, 0.993, 285, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 11
126, d5ka8A1, 0.9246, 1.34, 1.000, 285, 284, PROTEIN TYROSINE PHOSPHATASE 1B L192A MUTANT OPEN STATE
127, d1jf7A_, 0.9246, 1.25, 0.986, 284, 283, HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177836
128, d2fjnB1, 0.9243, 1.02, 1.000, 281, 281, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2
129, d1t49A_, 0.9239, 1.41, 1.000, 285, 284, ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B
130, d2fjmB1, 0.9236, 1.02, 0.996, 282, 281, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2
131, d1t4jA_, 0.9235, 0.94, 1.000, 281, 280, ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B
132, d3eu0A_, 0.9234, 1.03, 0.996, 282, 281, CRYSTAL STRUCTURE OF THE S-NITROSYLATED CYS215 OF PTP1B
133, d3a5jA1, 0.9232, 0.93, 1.000, 280, 280, CRYSTAL STRUCTURE OF PROTEIN-TYROSINE PHOSPHATASE 1B
134, d2fjmA1, 0.9232, 1.05, 0.996, 281, 281, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2
135, d1q6pB1, 0.9229, 0.95, 1.000, 281, 280, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 6
136, d5kabA_, 0.9228, 1.27, 0.996, 283, 282, PROTEIN TYROSINE PHOSPHATASE 1B DELTA HELIX 7 P185G MUTANT IN COMPLEX WITH TCS401 OPEN STATE
137, d5kadB1, 0.9225, 1.07, 0.996, 282, 281, PROTEIN TYROSINE PHOSPHATASE 1B N193A MUTANT IN COMPLEX WITH TCS401 CLOSED STATE
138, d2hnqA_, 0.9222, 0.70, 0.993, 279, 278, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE 1B
139, d2cm2A2, 0.9221, 0.75, 1.000, 278, 278, STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (P212121)
140, d4bjoB1, 0.9216, 1.05, 1.000, 281, 281, NITRATE IN THE ACTIVE SITE OF PTP1B IS A PUTATIVE MIMETIC OF THE TRANSITION STATE
141, d5ka2A_, 0.9206, 0.89, 1.000, 279, 279, PROTEIN TYROSINE PHOSPHATASE 1B YAYA (Y152A Y153A) MUTANT OPEN STATE
142, d2hnpA_, 0.9206, 1.05, 0.993, 280, 280, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE 1B
143, d2b4sA_, 0.9206, 0.81, 1.000, 278, 278, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE
144, d5ka0A_, 0.9201, 1.12, 0.989, 289, 280, PROTEIN TYROSINE PHOSPHATASE 1B DELTA HELIX 7 OPEN STATE
145, d1oetA_, 0.9197, 1.03, 1.000, 281, 280, OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
146, d1oeoX_, 0.9193, 0.95, 1.000, 279, 279, PTP1B WITH THE CATALYTIC CYSTEINE OXIDIZED TO SULFONIC ACID
147, d5ka4A_, 0.9191, 0.96, 1.000, 279, 279, PROTEIN TYROSINE PHOSPHATASE 1B T178A MUTANT OPEN STATE
148, d1oevA_, 0.9191, 1.05, 0.996, 280, 280, OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
149, d1oeuA_, 0.9191, 0.97, 1.000, 279, 279, OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
150, d2b4sC_, 0.9186, 0.96, 1.000, 279, 279, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE
151, d3a5kA_, 0.9183, 0.92, 0.996, 278, 278, CRYSTAL STRUCTURE OF PROTEIN-TYROSINE PHOSPHATASE 1B
152, d5kaaA_, 0.9178, 1.18, 0.993, 281, 281, PROTEIN TYROSINE PHOSPHATASE 1B DELTA HELIX 7 P185G MUTANT OPEN STATE
153, d5k9vA_, 0.9178, 1.10, 0.996, 281, 280, PROTEIN TYROSINE PHOSPHATASE 1B (1-301) OPEN STATE
154, d3smeA_, 0.9175, 1.02, 1.000, 279, 279, STRUCTURE OF PTP1B INACTIVATED BY H2O2/BICARBONATE
155, d5kacA_, 0.9169, 1.23, 1.000, 282, 281, PROTEIN TYROSINE PHOSPHATASE 1B P185G MUTANT OPEN STATE
156, d1oesA_, 0.9168, 1.05, 0.996, 279, 279, OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
157, d3cweA1, 0.9162, 1.25, 1.000, 281, 281, PTP1B IN COMPLEX WITH A PHOSPHONIC ACID INHIBITOR
158, d1i57A_, 0.9160, 0.83, 0.996, 278, 277, CRYSTAL STRUCTURE OF APO HUMAN PTP1B (C215S) MUTANT
159, p3zmpA_, 0.9150, 1.48, 0.996, 284, 284, SRC-DERIVED PEPTIDE INHIBITOR COMPLEX OF PTP1B
160, d2cmcA2, 0.9145, 0.75, 0.996, 276, 276, STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
161, d2cneA2, 0.9144, 1.11, 1.000, 279, 279, STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
162, d1oemX_, 0.9143, 1.12, 1.000, 279, 279, PTP1B WITH THE CATALYTIC CYSTEINE OXIDIZED TO A SULFENYL-AMIDE BOND
163, d2cmbA2, 0.9141, 1.24, 1.000, 280, 280, STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
164, d3zv2A_, 0.9121, 1.12, 1.000, 279, 279, HUMAN PROTEIN-TYROSINE PHOSPHATASE 1B C215A S216A MUTANT
165, d2cm3B_, 0.9027, 1.30, 0.993, 280, 280, STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (C2)
166, d2cm3A_, 0.9022, 0.95, 1.000, 274, 274, STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (C2)
167, d3ps5A3, 0.8882, 0.96, 1.000, 274, 274, CRYSTAL STRUCTURE OF THE FULL-LENGTH HUMAN PROTEIN TYROSINE PHOSPHATASE SHP-1
168, d1l8kA_, 0.8865, 1.97, 0.332, 314, 283, T CELL PROTEIN-TYROSINE PHOSPHATASE STRUCTURE
169, p3zmpB_, 0.8818, 1.97, 0.332, 314, 283, SRC-DERIVED PEPTIDE INHIBITOR COMPLEX OF PTP1B
170, d5xzrA3, 0.8757, 1.44, 0.703, 273, 273, THE ATOMIC STRUCTURE OF SHP2 E76A MUTANT IN COMPLEX WITH ALLOSTERIC INHIBITOR 9B
171, d4gwfA3, 0.8734, 0.75, 0.977, 266, 266, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION
172, d5ehpA3, 0.8731, 1.99, 0.341, 301, 279, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP836
173, d5ehrA3, 0.8726, 2.03, 0.341, 297, 279, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP099
174, d4h1oA3, 0.8722, 1.91, 0.347, 293, 277, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH D61G MUTATION
175, d4nwfB3, 0.8717, 1.92, 0.347, 294, 277, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION
176, d4nwgA3, 0.8696, 2.06, 0.344, 289, 279, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH E139D MUTATION
177, p6bmyA3, 0.8689, 2.02, 0.345, 292, 278, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP844
178, p6bmuA3, 0.8684, 2.06, 0.342, 294, 278, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP244
179, d2nlkA1, 0.8684, 1.87, 0.345, 287, 275, CRYSTAL STRUCTURE OF D1 AND D2 CATALYTIC DOMAINS OF HUMAN PROTEIN TYROSINE PHOSPHATASE GAMMA (D1+D2 PTPRG)
180, d4nwfA3, 0.8682, 1.88, 0.345, 287, 275, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION
181, d1larA1, 0.8678, 2.10, 0.342, 324, 278, CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP LAR
182, d4nwgB3, 0.8673, 2.10, 0.342, 324, 278, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH E139D MUTATION
183, d5hdeA_, 0.8671, 2.02, 0.343, 290, 277, CRYSTAL STRUCTURE OF PTPN12 CATALYTIC DOMAIN
184, d5ibmA3, 0.8670, 2.13, 0.386, 317, 277, STRUCTURE OF S502P A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
185, d4gwfB3, 0.8669, 2.05, 0.343, 292, 277, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION
186, d3sr9A1, 0.8668, 1.99, 0.329, 299, 277, CRYSTAL STRUCTURE OF MOUSE PTPSIGMA
187, d2i1yA_, 0.8665, 1.76, 0.350, 286, 274, CRYSTAL STRUCTURE OF THE PHOSPHATASE DOMAIN OF HUMAN PTP IA-2
188, d4dgxA3, 0.8654, 2.04, 0.339, 294, 277, LEOPARD SYNDROME-ASSOCIATED SHP2/Y279C MUTANT
189, d2c7sA1, 0.8650, 2.15, 0.379, 322, 277, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE KAPPA AT 1.95A RESOLUTION
190, d4dgpA3, 0.8646, 1.99, 0.359, 287, 276, THE WILD-TYPE SRC HOMOLOGY 2 (SH2)-DOMAIN CONTAINING PROTEIN TYROSINE PHOSPHATASE-2 (SHP2)
191, d5i6vB3, 0.8641, 1.85, 0.345, 284, 275, STRUCTURE OF F285S A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
192, d5i6vA3, 0.8640, 2.19, 0.329, 288, 277, STRUCTURE OF F285S A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
193, d4ohiA3, 0.8639, 1.80, 0.350, 283, 274, LEOPARD SYNDROME-ASSOCIATED SHP2/Q510E MUTANT
194, d5ibsA3, 0.8637, 1.84, 0.347, 288, 274, STRUCTURE OF E76Q A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
195, d4oheA3, 0.8636, 1.76, 0.348, 287, 273, LEOPARD SYNDROME-ASSOCIATED SHP2/G464A MUTANT
196, p3brhB_, 0.8633, 1.99, 0.344, 286, 276, PROTEIN TYROSINE PHOSPHATASE PTPN-22 (LYP) BOUND TO THE MONO-PHOSPHORYLATED LCK ACTIVE SITE PEPTIDE
197, p3brhA_, 0.8633, 1.76, 0.352, 287, 273, PROTEIN TYROSINE PHOSPHATASE PTPN-22 (LYP) BOUND TO THE MONO-PHOSPHORYLATED LCK ACTIVE SITE PEPTIDE
198, d2fh7A1, 0.8633, 1.83, 0.347, 283, 274, CRYSTAL STRUCTURE OF THE PHOSPHATASE DOMAINS OF HUMAN PTP SIGMA
199, d5ibsB3, 0.8630, 2.30, 0.333, 296, 279, STRUCTURE OF E76Q A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
200, d3qcnA_, 0.8630, 2.25, 0.333, 296, 279, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 TRIGONAL CRYSTAL FORM
201, d2b3oA3, 0.8629, 2.20, 0.372, 322, 277, CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE SHP-1
202, d4bpcA1, 0.8620, 2.20, 0.372, 322, 277, STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE SIGMA IN THE SULFENIC ACID FORM
203, d3qcdA_, 0.8620, 1.78, 0.352, 286, 273, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH VANADATE TRIGONAL CRYSTAL FORM
204, d3qckA_, 0.8619, 1.66, 0.351, 286, 271, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 2-[(34-DICHLOROBENZYL)SULFANYL]BENZOIC ACID
205, d3qcgA_, 0.8615, 2.16, 0.332, 294, 277, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 3-[(3-BROMO-4-CHLOROBENZYL)SULFANYL]THIOPHENE-2- CARBOXYLIC ACID
206, d3qccB_, 0.8613, 2.17, 0.370, 320, 276, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH VANADATE ORTHORHOMBIC CRYSTAL FORM
207, d2i1yB_, 0.8613, 1.54, 0.353, 283, 269, CRYSTAL STRUCTURE OF THE PHOSPHATASE DOMAIN OF HUMAN PTP IA-2
208, d5ibmB3, 0.8612, 2.00, 0.347, 289, 274, STRUCTURE OF S502P A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
209, d3qceA_, 0.8612, 1.69, 0.347, 286, 271, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 3-[(34-DICHLOROBENZYL)SULFANYL]THIOPHENE-2-CARBOXYLIC ACID VIA SOAKING
210, d4qunA1, 0.8609, 1.65, 0.352, 285, 270, CRYSTAL STRUCTURE OF THE PTPN3 (PTPH1) CATALYTIC DOMAIN C842S MUTANT
211, d4ri5A1, 0.8607, 2.05, 0.360, 290, 275, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) D811E MUTANT IN COMPLEX WITH METAVANADATE
212, d4ohhA3, 0.8604, 2.05, 0.360, 290, 275, LEOPARD SYNDROME-ASSOCIATED SHP2/Q506P MUTANT
213, d4ri5B1, 0.8602, 1.85, 0.352, 285, 273, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) D811E MUTANT IN COMPLEX WITH METAVANADATE
214, d2h03A_, 0.8602, 1.79, 0.346, 288, 272, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
215, d2pbnA_, 0.8594, 1.83, 0.344, 281, 273, CRYSTAL STRUCTURE OF THE HUMAN TYROSINE RECEPTOR PHOSPHATE GAMMA
216, d2shpB1, 0.8588, 1.73, 0.346, 281, 272, TYROSINE PHOSPHATASE SHP-2
217, d4qunB1, 0.8587, 1.82, 0.344, 282, 273, CRYSTAL STRUCTURE OF THE PTPN3 (PTPH1) CATALYTIC DOMAIN C842S MUTANT
218, d2shpA1, 0.8587, 1.74, 0.346, 280, 272, TYROSINE PHOSPHATASE SHP-2
219, d3qclA_, 0.8584, 2.23, 0.373, 288, 276, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 2-[(34-DICHLOROBENZYL)SULFANYL]-4-(4-HYDROXYBUT-1-YN-1- YL)BENZOIC ACID
220, d3i36A_, 0.8584, 1.60, 0.349, 285, 269, CRYSTAL STRUCTURE OF RAT PROTEIN TYROSINE PHOSPHATASE ETA CATALYTIC DOMAIN
221, p6bmyB3, 0.8581, 1.68, 0.348, 279, 270, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP844
222, p6bmuB3, 0.8580, 1.87, 0.344, 281, 273, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP244
223, p6bmwB3, 0.8579, 1.68, 0.348, 279, 270, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP504
224, d2qepA1, 0.8577, 2.03, 0.344, 289, 273, CRYSTAL STRUCTURE OF THE D1 DOMAIN OF PTPRN2 (IA2BETA)
225, d2pi7A_, 0.8577, 1.91, 0.333, 286, 273, STRUCTURE OF THE CATALYTIC DOMAIN OF THE CHICK RETINAL NEURITE INHIBITOR-RECEPTOR PROTEIN TYROSINE PHOSPHATASE CRYP-2/CPTPRO
226, p3zmqA_, 0.8576, 1.85, 0.349, 281, 272, SRC-DERIVED MUTANT PEPTIDE INHIBITOR COMPLEX OF PTP1B
227, d3qcbB_, 0.8565, 1.86, 0.349, 281, 272, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 APO
228, d4hjqA_, 0.8564, 1.86, 0.349, 281, 272, SHP-1 CATALYTIC DOMAIN WPD LOOP CLOSED
229, d4ri4A1, 0.8563, 1.92, 0.368, 286, 272, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) Y676I MUTANT IN COMPLEX WITH VANADATE
230, d2h4vB1, 0.8563, 1.84, 0.342, 294, 272, CRYSTAL STRUCTURE OF THE HUMAN TYROSINE RECEPTOR PHOSPHATASE GAMMA
231, d4ri4B_, 0.8561, 1.84, 0.342, 294, 272, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) Y676I MUTANT IN COMPLEX WITH VANADATE
232, d2qepB1, 0.8557, 0.62, 0.981, 258, 258, CRYSTAL STRUCTURE OF THE D1 DOMAIN OF PTPRN2 (IA2BETA)
233, d3qccA_, 0.8556, 1.75, 0.352, 285, 270, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH VANADATE ORTHORHOMBIC CRYSTAL FORM
234, d5ehpB3, 0.8555, 1.67, 0.340, 281, 268, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP836
235, d4hjqB_, 0.8554, 1.85, 0.346, 280, 272, SHP-1 CATALYTIC DOMAIN WPD LOOP CLOSED
236, d5j8rA_, 0.8553, 1.65, 0.349, 277, 269, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE 12 - K61R MUTANT
237, d3qcmB_, 0.8553, 1.93, 0.348, 281, 273, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 2-[(34-DICHLOROBENZYL)SULFANYL]-4-{[3-({N-[2- (METHYLAMINO)ETHYL]GLYCYL}AMINO)PHENYL]ETHYNYL}BENZOIC ACID
238, d3qciA_, 0.8551, 1.88, 0.369, 285, 271, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH N-[(3-AMINOPHENYL)SULFONYL]-3-[(34-DICHLOROBENZYL) SULFANYL]THIOPHENE-2-CARBOXAMIDE
239, d5ehrB3, 0.8548, 1.62, 0.351, 283, 268, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP099
240, d2ooqA1, 0.8547, 1.74, 0.352, 279, 270, CRYSTAL STRUCTURE OF THE HUMAN RECEPTOR PHOSPHATASE PTPRT
241, d4grzA_, 0.8546, 1.73, 0.336, 281, 268, CRYSTAL STRUCTURE OF SHP1 CATALYTIC DOMAIN WITH PO4
242, d1wchA_, 0.8546, 2.04, 0.328, 296, 274, CRYSTAL STRUCTURE OF PTPL1 HUMAN TYROSINE PHOSPHATASE MUTATED IN COLORECTAL CANCER - EVIDENCE FOR A SECOND PHOSPHOTYROSINE SUBSTRATE RECOGNITION POCKET
243, d4ohlB3, 0.8544, 2.03, 0.342, 288, 272, LEOPARD SYNDROME-ASSOCIATED SHP2/T468M MUTANT
244, d2g59A1, 0.8539, 1.88, 0.352, 285, 270, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE FROM HOMO SAPIENS
245, d2nv5B_, 0.8538, 1.76, 0.352, 279, 270, CRYSTAL STRUCTURE OF A C-TERMINAL PHOSPHATASE DOMAIN OF RATTUS NORVEGICUS ORTHOLOG OF HUMAN PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE D (PTPRD)
246, d2i4gA_, 0.8537, 1.58, 0.348, 277, 267, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH A SULFAMIC ACID (SOAKING EXPERIMENT)
247, d4h34A3, 0.8536, 1.76, 0.338, 282, 269, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Q506P MUTATION
248, d3qcmA_, 0.8530, 2.38, 0.332, 308, 277, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 2-[(34-DICHLOROBENZYL)SULFANYL]-4-{[3-({N-[2- (METHYLAMINO)ETHYL]GLYCYL}AMINO)PHENYL]ETHYNYL}BENZOIC ACID
249, d4ohlA3, 0.8528, 2.38, 0.332, 308, 277, LEOPARD SYNDROME-ASSOCIATED SHP2/T468M MUTANT
250, d3qcfA_, 0.8528, 1.71, 0.349, 278, 269, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 3-[(34-DICHLOROBENZYL)SULFANYL]THIOPHENE-2-CARBOXYLIC ACID VIA CO-CRYSTALLIZATION
251, d3qcjA_, 0.8526, 1.69, 0.353, 284, 269, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 5-[({3-[(34-DICHLOROBENZYL)SULFANYL]THIOPHEN-2- YL}CARBONYL)SULFAMOYL]-2-METHOXYBENZOIC ACID
252, d3qcbA_, 0.8525, 1.71, 0.372, 283, 269, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 APO
253, d3qchA_, 0.8523, 2.41, 0.379, 289, 277, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 3-[(34-DICHLOROBENZYL)SULFANYL]-N-(METHYLSULFONYL) THIOPHENE-2-CARBOXAMIDE
254, p6atdB2, 0.8522, 2.10, 0.343, 289, 274, OXIDIZED SHP2 FORMS A DISULFIDE BOND BETWEEN CYS367 AND CYS459 
255, d2ahsA_, 0.8521, 2.03, 0.347, 286, 271, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN TYROSINE RECEPTOR PHOSPHATASE BETA
256, p4gfvB_, 0.8519, 1.75, 0.349, 278, 269, PTPN18 IN COMPLEX WITH HER2-PY1196 PHOSPHOR-PEPTIDES
257, p6atdA2, 0.8516, 1.74, 0.349, 284, 269, OXIDIZED SHP2 FORMS A DISULFIDE BOND BETWEEN CYS367 AND CYS459 
258, d4j51B_, 0.8516, 1.87, 0.353, 285, 269, CYRSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE LYP CATALYTIC DOMAIN COMPLEX WITH SMALL MOLECULAR INHIBITOR L75N04
259, d2nv5A_, 0.8512, 1.67, 0.351, 283, 268, CRYSTAL STRUCTURE OF A C-TERMINAL PHOSPHATASE DOMAIN OF RATTUS NORVEGICUS ORTHOLOG OF HUMAN PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE D (PTPRD)
260, d2p6xA1, 0.8510, 1.93, 0.352, 284, 270, CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE PTPN22
261, d4j51A_, 0.8509, 1.75, 0.353, 275, 269, CYRSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE LYP CATALYTIC DOMAIN COMPLEX WITH SMALL MOLECULAR INHIBITOR L75N04
262, d5j8rB_, 0.8505, 2.00, 0.385, 281, 273, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE 12 - K61R MUTANT
263, d2ooqB1, 0.8502, 1.91, 0.324, 288, 272, CRYSTAL STRUCTURE OF THE HUMAN RECEPTOR PHOSPHATASE PTPRT
264, d2h4vA1, 0.8500, 1.91, 0.324, 288, 272, CRYSTAL STRUCTURE OF THE HUMAN TYROSINE RECEPTOR PHOSPHATASE GAMMA
265, d4ohdA3, 0.8497, 1.86, 0.352, 276, 270, LEOPARD SYNDROME-ASSOCIATED SHP2/A461T MUTANT
266, d2h02B_, 0.8496, 2.62, 0.341, 302, 279, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
267, d3h2xA_, 0.8491, 1.76, 0.372, 283, 269, CRYSTAL STRUCTURE OF THE HUMAN LYMPHOID TYROSINE PHOSPHATASE CATALYTIC DOMAIN
268, d1rpmB_, 0.8490, 2.64, 0.341, 301, 279, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU DOMAIN 1
269, d1rpmA_, 0.8490, 2.64, 0.341, 302, 279, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU DOMAIN 1
270, p3olrA_, 0.8488, 1.92, 0.332, 293, 271, PTPN22 IN COMPLEX WITH CONSENSUS PHOSPHO-TYROSINE PEPTIDE 1
271, d2nv5C_, 0.8486, 1.65, 0.352, 279, 267, CRYSTAL STRUCTURE OF A C-TERMINAL PHOSPHATASE DOMAIN OF RATTUS NORVEGICUS ORTHOLOG OF HUMAN PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE D (PTPRD)
272, p3olrB_, 0.8484, 1.66, 0.352, 273, 267, PTPN22 IN COMPLEX WITH CONSENSUS PHOSPHO-TYROSINE PEPTIDE 1
273, d6bn5B2, 0.8483, 2.11, 0.339, 284, 274, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 F285S IN COMPLEX WITH ALLOSTERIC INHIBITOR JLR-2
274, p3olrC_, 0.8480, 2.09, 0.379, 283, 272, PTPN22 IN COMPLEX WITH CONSENSUS PHOSPHO-TYROSINE PEPTIDE 1
275, p3olrD_, 0.8479, 2.61, 0.339, 302, 280, PTPN22 IN COMPLEX WITH CONSENSUS PHOSPHO-TYROSINE PEPTIDE 1
276, d5awxA1, 0.8477, 2.61, 0.339, 302, 280, CRYSTAL STRUCTURE OF HUMAN PTPRZ D1 DOMAIN
277, p4s0gA_, 0.8476, 1.74, 0.345, 278, 267, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) IN COMPLEX WITH EPS15 PTYR849 P850V PEPTIDE
278, p3omhA_, 0.8476, 1.74, 0.345, 278, 267, CRYSTAL STRUCTURE OF PTPN22 IN COMPLEX WITH SKAP-HOM PTYR75 PEPTIDE
279, p3omhC_, 0.8473, 2.40, 0.342, 297, 275, CRYSTAL STRUCTURE OF PTPN22 IN COMPLEX WITH SKAP-HOM PTYR75 PEPTIDE
280, d2p6xB_, 0.8471, 1.80, 0.372, 283, 269, CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE PTPN22
281, d3s3eB1, 0.8470, 2.40, 0.342, 297, 275, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER
282, d2pi7B_, 0.8468, 1.70, 0.352, 275, 267, STRUCTURE OF THE CATALYTIC DOMAIN OF THE CHICK RETINAL NEURITE INHIBITOR-RECEPTOR PROTEIN TYROSINE PHOSPHATASE CRYP-2/CPTPRO
283, p3omhB_, 0.8467, 2.41, 0.342, 297, 275, CRYSTAL STRUCTURE OF PTPN22 IN COMPLEX WITH SKAP-HOM PTYR75 PEPTIDE
284, d2i3rA_, 0.8467, 2.40, 0.342, 297, 275, ENGINEERED CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE HPTPBETA
285, p4rh5A_, 0.8465, 1.75, 0.351, 281, 268, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) IN COMPLEX WITH EPS15 PTYR849 PEPTIDE
286, p4gfvA_, 0.8462, 1.93, 0.343, 279, 271, PTPN18 IN COMPLEX WITH HER2-PY1196 PHOSPHOR-PEPTIDES
287, p3s3hB_, 0.8458, 2.39, 0.342, 294, 275, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A PHOSPHOPEPTIDE SUBSTRATE GP4
288, p4rhgA_, 0.8457, 2.40, 0.345, 294, 275, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) D811E C842S MUTANT IN COMPLEX WITH EPS15 PTYR849 PEPTIDE
289, d3s3fB1, 0.8456, 2.70, 0.341, 296, 279, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A SMALL MOLECULE INHIBITOR VANADATE
290, p3s3hA_, 0.8453, 1.81, 0.357, 282, 269, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A PHOSPHOPEPTIDE SUBSTRATE GP4
291, d3s3eA1, 0.8453, 1.93, 0.341, 289, 270, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER
292, d2gjtA1, 0.8453, 2.07, 0.335, 291, 272, CRYSTAL STRUCTURE OF THE HUMAN RECEPTOR PHOSPHATASE PTPRO
293, p3s3kB_, 0.8452, 2.05, 0.391, 286, 271, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A SMALL MOLECULAR INHIBITOR PARA-NITROCATECHOL SULPHATE
294, d3s3fA1, 0.8451, 2.05, 0.342, 280, 272, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A SMALL MOLECULE INHIBITOR VANADATE
295, d3qcfB_, 0.8451, 1.83, 0.323, 286, 269, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 3-[(34-DICHLOROBENZYL)SULFANYL]THIOPHENE-2-CARBOXYLIC ACID VIA CO-CRYSTALLIZATION
296, d3qceB_, 0.8449, 1.83, 0.357, 285, 269, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 3-[(34-DICHLOROBENZYL)SULFANYL]THIOPHENE-2-CARBOXYLIC ACID VIA SOAKING
297, d2i4eA_, 0.8439, 2.19, 0.341, 282, 273, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
298, p4nndA_, 0.8436, 2.19, 0.341, 282, 273, STRUCTURAL BASIS OF PTPN18 FINGERPRINT ON DISTINCT HER2 TYROSINE PHOSPHORYLATION SITES
299, d2bzlA_, 0.8433, 1.83, 0.357, 282, 269, CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE N14 AT 1.65 A RESOLUTION
300, d2i75A_, 0.8432, 1.85, 0.357, 287, 269, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE N4 (PTPN4)
301, d2i5xA_, 0.8431, 1.85, 0.357, 287, 269, ENGINEERING THE PTPBETA CATALYTIC DOMAIN WITH IMPROVED CRYSTALLIZATION PROPERTIES
302, d2h04A_, 0.8431, 1.85, 0.357, 282, 269, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
303, p3omhD_, 0.8430, 2.26, 0.350, 293, 274, CRYSTAL STRUCTURE OF PTPN22 IN COMPLEX WITH SKAP-HOM PTYR75 PEPTIDE
304, d2i5xB_, 0.8422, 1.84, 0.357, 285, 269, ENGINEERING THE PTPBETA CATALYTIC DOMAIN WITH IMPROVED CRYSTALLIZATION PROPERTIES
305, p4nndB_, 0.8418, 1.86, 0.357, 282, 269, STRUCTURAL BASIS OF PTPN18 FINGERPRINT ON DISTINCT HER2 TYROSINE PHOSPHORYLATION SITES
306, p6bmxB2, 0.8416, 1.96, 0.351, 284, 268, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP844
307, d6bn5A3, 0.8409, 1.97, 0.351, 284, 268, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 F285S IN COMPLEX WITH ALLOSTERIC INHIBITOR JLR-2
308, d1yfoB_, 0.8402, 2.01, 0.390, 281, 269, RECEPTOR PROTEIN TYROSINE PHOSPHATASE ALPHA DOMAIN 1 FROM MOUSE
309, d1yfoA_, 0.8401, 1.82, 0.332, 283, 268, RECEPTOR PROTEIN TYROSINE PHOSPHATASE ALPHA DOMAIN 1 FROM MOUSE
310, p4nndD_, 0.8394, 2.01, 0.333, 284, 270, STRUCTURAL BASIS OF PTPN18 FINGERPRINT ON DISTINCT HER2 TYROSINE PHOSPHORYLATION SITES
311, d5j8rC_, 0.8393, 2.01, 0.333, 284, 270, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE 12 - K61R MUTANT
312, d2i4eB_, 0.8391, 1.75, 0.375, 273, 267, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
313, d5h08A1, 0.8387, 1.94, 0.392, 280, 268, HUMAN PTPRZ D1 DOMAIN COMPLEXED WITH NAZ2329
314, d2hc1A_, 0.8378, 1.99, 0.384, 280, 268, ENGINEERED CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE HPTPBETA.
315, d5j8rD_, 0.8375, 2.43, 0.342, 294, 275, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE 12 - K61R MUTANT
316, d2h02A_, 0.8370, 2.06, 0.390, 281, 269, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
317, d2qctB_, 0.8369, 1.87, 0.332, 283, 268, STRUCTURE OF LYP WITH INHIBITOR I-C11
318, d2oc3A_, 0.8357, 1.83, 0.353, 269, 266, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE 18
319, d2hy3B_, 0.8353, 1.65, 0.352, 272, 264, CRYSTAL STRUCTURE OF THE HUMAN TYROSINE RECEPTOR PHOSPHATE GAMMA IN COMPLEX WITH VANADATE
320, d2gjtB1, 0.8352, 1.65, 0.352, 279, 264, CRYSTAL STRUCTURE OF THE HUMAN RECEPTOR PHOSPHATASE PTPRO
321, d2hy3A_, 0.8351, 1.73, 0.351, 279, 265, CRYSTAL STRUCTURE OF THE HUMAN TYROSINE RECEPTOR PHOSPHATE GAMMA IN COMPLEX WITH VANADATE
322, d2hc2A_, 0.8351, 1.85, 0.337, 281, 267, ENGINEERED PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN
323, d2i4hA_, 0.8342, 1.96, 0.332, 286, 268, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN CO-CRYSTALLIZED WITH A SULFAMIC ACID INHIBITOR
324, p4nndG_, 0.8321, 2.07, 0.392, 280, 268, STRUCTURAL BASIS OF PTPN18 FINGERPRINT ON DISTINCT HER2 TYROSINE PHOSPHORYLATION SITES
325, d2i3rB_, 0.8302, 1.88, 0.357, 280, 266, ENGINEERED CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE HPTPBETA
326, d2qcjB_, 0.8281, 2.51, 0.380, 288, 274, NATIVE STRUCTURE OF LYP
327, d2qcjA_, 0.8268, 2.02, 0.332, 284, 268, NATIVE STRUCTURE OF LYP
328, d2qctA_, 0.8258, 1.90, 0.395, 278, 266, STRUCTURE OF LYP WITH INHIBITOR I-C11
329, d2a8bA1, 0.8251, 2.41, 0.353, 285, 272, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN TYROSINE PHOSPHATASE RECEPTOR TYPE R
330, d1zepA1, 0.8251, 1.79, 0.332, 279, 265,  
331, d2ahsB_, 0.8229, 1.46, 0.354, 270, 260, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN TYROSINE RECEPTOR PHOSPHATASE BETA
332, d4az1A_, 0.8225, 1.91, 0.346, 275, 266, CRYSTAL STRUCTURE OF THE TRYPANOSOMA CRUZI PROTEIN TYROSINE PHOSPHATASE TCPTP1 A POTENTIAL THERAPEUTIC TARGET FOR CHAGAS  DISEASE
333, d4hjpA_, 0.8215, 1.57, 0.349, 270, 261, SHP-1 CATALYTIC DOMAIN WPD LOOP OPEN
334, d1jlnA1, 0.8210, 2.13, 0.390, 283, 269, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE PTP-SL/BR7
335, d4az1B_, 0.8193, 2.33, 0.383, 280, 269, CRYSTAL STRUCTURE OF THE TRYPANOSOMA CRUZI PROTEIN TYROSINE PHOSPHATASE TCPTP1 A POTENTIAL THERAPEUTIC TARGET FOR CHAGAS  DISEASE
336, d2qdpA_, 0.8170, 1.82, 0.333, 278, 264, CRYSTAL STRUCTURE OF THE HEPTP CATALYTIC DOMAIN C270S MUTANT CRYSTALLIZED IN AMMONIUM ACETATE
337, p4gfuA_, 0.8166, 2.13, 0.393, 278, 267, PTPN18 IN COMPLEX WITH HER2-PY1248 PHOSPHOR-PEPTIDES
338, d2nz6A1, 0.8161, 2.17, 0.345, 280, 267, CRYSTAL STRUCTURE OF THE PTPRJ INACTIVATING MUTANT C1239S
339, d3zm3A1, 0.8160, 2.19, 0.348, 280, 267, CATALYTIC DOMAIN OF HUMAN SHP2
340, d3m4uA_, 0.8155, 2.03, 0.341, 282, 264, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI PROTEIN TYROSINE PHOSPHATASE TBPTP1
341, d3o4sA_, 0.8131, 2.35, 0.311, 281, 270, CRYSTAL STRUCTURE OF HEPTP WITH A CLOSED WPD LOOP AND AN ORDERED E- LOOP
342, d4pvgA_, 0.8126, 2.35, 0.311, 281, 270, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE SHP2 CATALYTIC DOMAIN COMPLEX WITH SMALL MOLECULAR COMPOUND L88N79
343, p4gs0A_, 0.8115, 2.18, 0.385, 272, 265, CRYSTAL STRUCTURE OF SHP1 CATALYTIC DOMAIN WITH JAK1 ACTIVATION LOOP PEPTIDE
344, d3zm2A1, 0.8111, 2.39, 0.245, 294, 269, CATALYTIC DOMAIN OF HUMAN SHP2
345, d4ikcA1, 0.8100, 2.39, 0.245, 294, 269, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF PTPRQ
346, d1fprA_, 0.8100, 2.29, 0.352, 281, 264, CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN THE CATALYTIC DOMAIN OF SHP-1 AND AN IN VITRO PEPTIDE SUBSTRATE PY469 DERIVED FROM SHPS-1.
347, d2b49A_, 0.8080, 2.35, 0.301, 295, 269, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE 3
348, d3m4uB_, 0.8078, 2.35, 0.301, 295, 269, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI PROTEIN TYROSINE PHOSPHATASE TBPTP1
349, d3d42A_, 0.8070, 2.39, 0.245, 292, 269, CRYSTAL STRUCTURE OF HEPTP IN COMPLEX WITH A MONOPHOSPHORYLATED ERK2 PEPTIDE
350, d3zm0A1, 0.8067, 2.44, 0.328, 292, 268, CATALYTIC DOMAIN OF HUMAN SHP2
351, p4gs0B_, 0.8066, 1.74, 0.341, 268, 258, CRYSTAL STRUCTURE OF SHP1 CATALYTIC DOMAIN WITH JAK1 ACTIVATION LOOP PEPTIDE
352, d2gp0A_, 0.8066, 1.80, 0.337, 290, 258, HEPTP CATALYTIC DOMAIN (RESIDUES 44-339) S225D MUTANT
353, d1zc0A_, 0.8058, 1.80, 0.337, 290, 258, CRYSTAL STRUCTURE OF HUMAN HEMATOPOIETIC TYROSINE PHOSPHATASE (HEPTP) CATALYTIC DOMAIN
354, d2g59B1, 0.8055, 1.85, 0.366, 263, 257, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE FROM HOMO SAPIENS
355, d2bv5A_, 0.8048, 2.30, 0.277, 285, 267, CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN5 AT 1.8A RESOLUTION
356, d5ovxA1, 0.8041, 2.66, 0.327, 293, 269, X-RAY CHARACTERIZATION OF STRIATAL-ENRICHED PROTEIN TYROSINE PHOSPHATASE INHIBITORS
357, d2i3uA_, 0.8038, 1.76, 0.367, 264, 256, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
358, d5ovrA1, 0.8035, 1.99, 0.359, 267, 256, X-RAY CHARACTERIZATION OF STRIATAL-ENRICHED PROTEIN TYROSINE PHOSPHATASE INHIBITORS
359, d1gwzA_, 0.8026, 1.68, 0.366, 259, 254, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTEIN TYROSINE PHOSPHATASE SHP-1
360, d3d44A_, 0.8022, 1.89, 0.317, 272, 259, CRYSTAL STRUCTURE OF HEPTP IN COMPLEX WITH A DUALLY PHOSPHORYLATED ERK2 PEPTIDE MIMETIC
361, d2qdmA_, 0.8014, 1.89, 0.317, 272, 259, CRYSTAL STRUCTURE OF THE HEPTP CATALYTIC DOMAIN C270S/D236A/Q314A MUTANT
362, d2hvlA_, 0.8012, 2.50, 0.348, 284, 264, CRYSTAL STRUCTURE OF THE HEPTP CATALYTIC DOMAIN C270S MUTANT
363, d2bijA1, 0.8002, 1.65, 0.366, 259, 254, CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN5 (STEP STRIATUM ENRICHED ENRICHED PHOSPHATASE)
364, d3zm1A1, 0.7995, 2.29, 0.277, 283, 264, CATALYTIC DOMAIN OF HUMAN SHP2
365, d2qdcA_, 0.7993, 2.54, 0.328, 289, 265, CRYSTAL STRUCTURE OF THE HEPTP CATALYTIC DOMAIN D236A MUTANT
366, d3b7oA_, 0.7989, 1.65, 0.373, 257, 252, CRYSTAL STRUCTURE OF THE HUMAN TYROSINE PHOSPHATASE SHP2 (PTPN11) WITH AN ACCESSIBLE ACTIVE SITE
367, d4rddA_, 0.7987, 1.68, 0.361, 258, 252, CO-CRYSTAL STRUCTURE OF SHP2 IN COMPLEX WITH A CEFSULODIN DERIVATIVE
368, d5ow1A1, 0.7961, 2.42, 0.330, 288, 264, X-RAY CHARACTERIZATION OF STRIATAL-ENRICHED PROTEIN TYROSINE PHOSPHATASE INHIBITORS
369, p6bmrA3, 0.7958, 2.38, 0.331, 286, 263, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP244
370, d4gryA_, 0.7952, 2.21, 0.352, 274, 261, CRYSTAL STRUCTURE OF SHP1 CATALYTIC DOMAIN WITH SO4
371, p6bmxA3, 0.7951, 2.57, 0.302, 281, 268, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP844
372, d3o5xA_, 0.7919, 2.60, 0.306, 279, 268, CRYSTAL STRUCTURE OF THE ONCOGENIC TYROSINE PHOSPHATASE SHP2 COMPLEXED WITH A SALICYLIC ACID-BASED SMALL MOLECULE INHIBITOR
373, d3jrlA_, 0.7910, 2.43, 0.380, 276, 263,  
374, p6bmrB3, 0.7891, 2.61, 0.306, 279, 268, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP244
375, p6bmvA3, 0.7890, 2.04, 0.357, 280, 255, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP504
376, d3mowA_, 0.7883, 2.51, 0.323, 284, 263, CRYSTAL STRUCTURE OF SHP2 IN COMPLEX WITH A TAUTOMYCETIN ANALOG TTN D- 2 1
377, p6bmvB3, 0.7869, 2.56, 0.316, 286, 263, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP504
378, d1larB1, 0.7853, 2.34, 0.326, 285, 261, CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP LAR
379, d3o4tA_, 0.7829, 2.55, 0.308, 277, 266, CRYSTAL STRUCTURE OF HEPTP WITH AN OPEN WPD LOOP AND PARTIALLY DEPLETED ACTIVE SITE
380, d2cjzA1, 0.7756, 1.66, 0.372, 255, 250, CRYSTAL STRUCTURE OF THE C472S MUTANT OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN5 (STEP STRIATUM ENRICHED PHOSPHATASE) IN COMPLEX WITH PHOSPHOTYROSINE
381, d3o4uA_, 0.7754, 2.39, 0.322, 284, 261, CRYSTAL STRUCTURE OF HEPTP WITH AN ATYPICALLY OPEN WPD LOOP
382, d2a3kA_, 0.7731, 2.04, 0.374, 272, 254, CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN7 (HEPTP HEMATOPOIETIC PROTEIN TYROSINE PHOSPHATASE)
383, d1larB2, 0.7722, 1.92, 0.372, 267, 253, CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP LAR
384, d1larA2, 0.7715, 2.56, 0.306, 276, 265, CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP LAR
385, d4bpcA2, 0.7664, 1.65, 0.378, 253, 249, STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE SIGMA IN THE SULFENIC ACID FORM
386, d2fh7A2, 0.7656, 2.30, 0.340, 271, 256, CRYSTAL STRUCTURE OF THE PHOSPHATASE DOMAINS OF HUMAN PTP SIGMA
387, d1p15B_, 0.7613, 1.67, 0.378, 253, 249, CRYSTAL STRUCTURE OF THE D2 DOMAIN OF RPTPA
388, d3sr9A2, 0.7597, 1.77, 0.373, 255, 249, CRYSTAL STRUCTURE OF MOUSE PTPSIGMA
389, d1p15A_, 0.7536, 1.80, 0.373, 255, 249, CRYSTAL STRUCTURE OF THE D2 DOMAIN OF RPTPA
390, d2cfvA1, 0.7501, 1.78, 0.375, 249, 248, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE J
391, d1ytwA_, 0.7397, 1.75, 0.379, 249, 248, YERSINIA PTPASE COMPLEXED WITH TUNGSTATE
392, d2i42A_, 0.7395, 1.80, 0.379, 254, 248, CRYSTAL STRUCTURE OF YERSINIA PROTEIN TYROSINE PHOSPHATASE COMPLEXED WITH VANADATE A TRANSITION STATE ANALOGUE
393, d1lyvA_, 0.7395, 1.83, 0.375, 249, 248, HIGH-RESOLUTION STRUCTURE OF THE CATALYTICALLY INACTIVE YERSINIA TYROSINE PHOSPHATASE C403A MUTANT IN COMPLEX WITH PHOSPHATE.
394, d3bm8A_, 0.7394, 2.07, 0.410, 284, 249, CRYSTAL STRUCTURE OF YOPH MUTANT D356A COMPLEXED WITH IRREVERSIBLE INHIBITOR PVSN
395, d1ytnA_, 0.7393, 2.54, 0.331, 281, 257, HYDROLASE
396, d1xxpB1, 0.7388, 2.55, 0.304, 268, 257, YERSINIA YOPH (RESIDUES 163-468) C403S BINDS PHOSPHOTYROSYL PEPTIDE AT TWO SITES
397, d3bluA_, 0.7387, 2.50, 0.331, 276, 254, CRYSTAL STRUCTURE YOPH COMPLEXED WITH INHIBITOR PVS
398, d1xxpA1, 0.7386, 2.30, 0.323, 272, 251, YERSINIA YOPH (RESIDUES 163-468) C403S BINDS PHOSPHOTYROSYL PEPTIDE AT TWO SITES
399, d3u96B_, 0.7381, 1.88, 0.332, 249, 244, CRYSTAL STRUCTURE OF YOPHQ357F(CATALYTIC DOMAIN RESIDUES 163-468) IN COMPLEX WITH PNCS
400, d1xxvB1, 0.7381, 1.88, 0.332, 249, 244, YERSINIA YOPH (RESIDUES 163-468) BINDS PHOSPHONODIFLUOROMETHYL-PHE CONTAINING HEXAPEPTIDE AT TWO SITES
401, d1xxvA1, 0.7380, 1.88, 0.332, 249, 244, YERSINIA YOPH (RESIDUES 163-468) BINDS PHOSPHONODIFLUOROMETHYL-PHE CONTAINING HEXAPEPTIDE AT TWO SITES
402, d3bltA_, 0.7377, 1.77, 0.353, 246, 241, CRYSTAL STRUCTURES OF YOPH COMPLEXED WITH PVSN AND PVS INHIBITORS OF YOPH WHICH CO-VALENT BIND TO CYS OF ACTIVE SITE
403, d2yduA_, 0.7375, 1.79, 0.353, 246, 241, CRYSTAL STRUCTURE OF YOPH IN COMPLEX WITH 3-(11-DIOXIDO-3-OXOISOTHIAZOLIDIN-5-YL)BENZALDEYDE
404, d1pa9A_, 0.7375, 1.91, 0.351, 246, 242, YERSINIA PROTEIN-TYROSINE PHOSPHATASE COMPLEXED WITH PNCS (YOP51PASTEURELLA XPTPASEYOP51DELTA162) (CATALYTIC DOMAIN RESIDUES 163-468) MUTANT WITH CYS 235 REPLACED BY ARG (C235R)
405, d2y2fA_, 0.7370, 1.92, 0.344, 246, 241, CRYSTAL STRUCTURE OF YERSINIA PESTIS YOPH IN COMPLEX WITH AN AMINOOXY-CONTAINING PLATFORM COMPOUND FOR INHIBITOR DESIGN
406, d1qz0B_, 0.7363, 1.98, 0.353, 245, 241, CRYSTAL STRUCTURE OF THE YERSINIA PESTIS PHOSPHATASE YOPH IN COMPLEX WITH A PHOSPHOTYROSYL MIMETIC-CONTAINING HEXAPEPTIDE
407, d1qz0A_, 0.7363, 1.64, 0.339, 248, 236, CRYSTAL STRUCTURE OF THE YERSINIA PESTIS PHOSPHATASE YOPH IN COMPLEX WITH A PHOSPHOTYROSYL MIMETIC-CONTAINING HEXAPEPTIDE
408, d3f9aA_, 0.7333, 2.94, 0.163, 283, 251, W354F YERSINIA ENTEROCOLITICA PTPASE COMPLEXED WITH TUNGSTATE
409, d4zn5A_, 0.7329, 2.84, 0.164, 282, 250, YOPH W354Y YERSINIA ENTEROCOLITICA PTPASE BOND WITH DIVANADATE GLYCEROL ESTER IN THE ACTIVE SITE
410, d4yaaA_, 0.7326, 2.92, 0.159, 283, 251, YOPH W354Y YERSINIA ENTEROCOLITICA PTPASE APO FORM
411, d3f9bA_, 0.7326, 2.92, 0.159, 283, 251, W354F YERSINIA ENTEROCOLITICA PTPASE COMPLEXED WITH DIVANADATE
412, d4zi4A_, 0.7325, 2.76, 0.165, 282, 249, YOPH W354H YERSINIA ENTEROCOLITICA PTPASE BOND WITH DIVANADATE GLYCEROL ESTER IN THE ACTIVE SITE
413, d3u96A_, 0.7320, 2.94, 0.163, 283, 251, CRYSTAL STRUCTURE OF YOPHQ357F(CATALYTIC DOMAIN RESIDUES 163-468) IN COMPLEX WITH PNCS
414, d4z6bA_, 0.7317, 2.91, 0.159, 283, 251, YOPH W354H YERSINIA ENTEROCOLITICA PTPASE IN THE APO FORM
415, d3f99A_, 0.7315, 2.84, 0.164, 282, 250, W354F YERSINIA ENTEROCOLITICA PTPASE APO FORM
416, d1yptB_, 0.7291, 2.92, 0.159, 283, 251, CRYSTAL STRUCTURE OF YERSINIA PROTEIN TYROSINE PHOSPHATASE AT 2.5 ANGSTROMS AND THE COMPLEX WITH TUNGSTATE
417, d1ytsA_, 0.7270, 2.85, 0.168, 282, 250, A LIGAND-INDUCED CONFORMATIONAL CHANGE IN THE YERSINIA PROTEIN TYROSINE PHOSPHATASE
418, d1yptA_, 0.7226, 2.79, 0.165, 282, 249, CRYSTAL STRUCTURE OF YERSINIA PROTEIN TYROSINE PHOSPHATASE AT 2.5 ANGSTROMS AND THE COMPLEX WITH TUNGSTATE
419, d1g4wR2, 0.6992, 2.79, 0.165, 282, 249, CRYSTAL STRUCTURE OF THE SALMONELLA TYROSINE PHOSPHATASE AND GTPASE ACTIVATING PROTEIN SPTP
420, d1g4uS2, 0.6823, 2.79, 0.165, 282, 249, CRYSTAL STRUCTURE OF THE SALMONELLA TYROSINE PHOSPHATASE AND GTPASE ACTIVATING PROTEIN SPTP BOUND TO RAC1
421, d2nlkA2, 0.6732, 2.87, 0.164, 282, 250, CRYSTAL STRUCTURE OF D1 AND D2 CATALYTIC DOMAINS OF HUMAN PROTEIN TYROSINE PHOSPHATASE GAMMA (D1+D2 PTPRG)
422, p5xw4A2, 0.5173, 2.96, 0.163, 279, 251, CRYSTAL STRUCTURE OF BUDDING YEAST CDC14P (WILD TYPE) IN THE APO STATE
423, p6b8zA1, 0.5056, 2.87, 0.164, 282, 250, MULTICONFORMER MODEL OF WT PTP1B WITH BB3 AT 273 K 
424, p3v0hB1, 0.5013, 2.88, 0.164, 282, 250, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) COMPLEXED WITH D-MYO- INOSITOL-145-TRIPHOSPHATE
425, d1fq1A_, 0.5001, 2.88, 0.164, 282, 250, CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) IN COMPLEX WITH PHOSPHO-CDK2
